{"database": "lobbying", "table": "lobbying_activities", "rows": [[2466139, "2c483abd-28c1-4119-8308-7f68fb26c957", "Q2", "THE SMITH-FREE GROUP, LLC", 35800, "UNIVERSAL CORPORATION", 2020, "second_quarter", "CSP", "Monitored FDA actions to establish a CBD regulatory framework", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2020-07-15T11:53:13.743000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2466139"], "units": {}, "query_ms": 15.146172023378313, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}